Drugs / mRNA-1018-H5
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT07496450 | Mar 2026 → Jan 2027 expected | influenza | ModernaTX, Inc. | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | mRNA-1018-H5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07496450 ↗ |
| Route | Intramuscular | “by intramuscular (IM) injection” NCT07496450 ↗ |